bibliographic entry 12414283 [be/12414283]
https://w3id.org/oc/corpus/be/12414283

is a

• bibliographic reference

content

• Johnson, PJ, Qin, S, Park, J-W, Poon, RTP, Raoul, J-L, Philip, PA, Cheng, A-L. Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study, Journal of Clinical Oncology, JCO, 2013, 2012, 48, 4410

references

• https://w3id.org/oc/corpus/br/8212786